Meeting
2018 Genitourinary Cancers Symposium
Germline pathologic mutations and cancer family history in prostate cancer patients.
Authors
Marcus Marie Moses
Tulane University, New Orleans, LA
Marcus Marie Moses , Elisa Ledet , Emma M. Ernst , Patrick Cotogno , Joshua Schiff , Brian E. Lewis , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 378)
DOI
10.1200/JCO.2018.36.6_suppl.378
Abstract #
378
Poster Bd #
F3
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline testing for men with prostate cancer: Need to broaden the indications in Europe?
First Author: Elena Trevisi
Poster
2022 ASCO Genitourinary Cancers Symposium
Correlation of the rate of metastasis-free survival with the presence of pathogenic germline genetic mutations in patients with prostate cancer at a community practice.
First Author: Siddharth Ramanathan
Poster
2023 ASCO Annual Meeting
Socio-demographic, clinical, and genetic predictors of low versus high Gleason score among men with prostate cancer in the Detroit Research on Cancer Survivorship (ROCS) cohort.
First Author: Samantha Goodenow